Navigation Links
New clinical trial explores use of smartphone application for postpartum weight loss
Date:12/5/2012

CLEVELAND In a first-of-its-kind clinical trial, physician-researchers at University Hospitals (UH) Case Medical Center MacDonald Women's Hospital are exploring the use of "Lose It!," a free Smartphone application (app), for postpartum weight loss. Principal Investigator Justin Lappen, MD, Assistant Director, Residency Program, Department of OB/GYN at UH Case Medical Center MacDonald Women's Hospital, is recruiting postpartum patients to measure the effectiveness of using a Smartphone app to lose weight after pregnancy.

"Smartphones and Smartphone app usage has quickly transformed the way people communicate and track their daily schedules and behaviors," says Dr. Lappen, who is also Assistant Professor at Case Western Reserve University School of Medicine. "Obesity has become such a major problem in the U.S. among young women and excess weight gain during pregnancy is harder to lose and may contribute to the obesity epidemic. We are looking to evaluate the correlation of using a Smartphone app and weight loss for postpartum women."

Results from previous studies that evaluated the role of diet/nutrition counseling and exercise on weight loss in postpartum women have shown only modest impact on weight reduction. No prior studies have evaluated the use of a Smartphone app dedicated to tracking nutrition and exercise to facilitate weight loss.

Lose It! app users can log all diet and exercise activity on their Smartphone. The app features a sophisticated weight tracker, dining out calorie counter, and calculates calories burned by exercise.

According to the American College of Obstetricians and Gynecologists one third of adult women in the United States are obese. During pregnancy, obese women are at increased risk for maternal and fetal complications and excess weight gain during pregnancy substantially contributes to postpartum weight retention and the obesity epidemic.


'/>"/>

Contact: Alicia Reale
alicia.reale@uhhospitals.org
216-844-5158
University Hospitals Case Medical Center
Source:Eurekalert

Page: 1

Related biology news :

1. Clinical trial tests rice bran to prevent cancer
2. Greenphire CEO Sam Whitaker speaks on Sunshine Act and Clinical Trial Payments
3. TESARO and Virginia G. Piper Cancer Center announce first patient in clinical trial of TSR-011
4. Clinical hypnosis can reduce hot flashes after menopause, Baylor study shows
5. BioLife Solutions Products Now Used in More than 50 Clinical Trial-Stage Cellular Therapies
6. Advanced Clinical Joins MedNet Solutions iMedNet Partner Program
7. New Market Forecasts Available for Critical Global Biotechnology Testing and Screening Markets: Molecular Diagnostics, Hematology, Clinical Chemistry and Nucleic Acid Testing
8. BioFortis Inc., Introduces Next Generation Biobanking Software Platform for Biomarker-Based Clinical Research
9. International Life Sciences Conferences Address Advancements in High-Content Analysis, Sample Preparation, Clinical Trial Supply and Protein and Antibody Engineering
10. MedNet Solutions Announces Latest Enhancements To Its iMedNet EDC eClinical Solution
11. Therapies for spinal cord injury: On the cutting edge of clinical translation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... a molecular testing panel developed at UPMC greatly ... surgery for patients with thyroid nodules and cancer, ... Institute (UPCI), partner with UPMC CancerCenter., The test, ... other diagnostic testing agencies, improved the chances of ... percent, according to the study published this month ...
(Date:7/24/2014)... NEW YORK, NY (July 24, 2014) Scientists ... Research Institute are one step closer to creating ... from a patient,s own cells. , For ... stem (iPS) cells lines from skin samples of ... they developed an accelerated protocol to induce these ...
(Date:7/24/2014)... /PRNewswire-iReach/ -- The Geneva Healthcare Suite, an innovative technology ... emergency room wait times by an average of 92 ... according to a recent study published in the Academic ... the suite to access data from incoming patients, implanted ... "Using Geneva,s technology platform we have been able to ...
Breaking Biology News(10 mins):Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3NYSCF scientists one step closer to cell therapy for multiple sclerosis patients 2UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 2UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite 3
... to develop and evaluate new tools to control the ... five year, 12 million project involving sixteen partners in ... Framework programme. Because malaria is transmitted by mosquitoes, ... Wide scale use of insecticides on bednets and ...
... has long been used as a crop fertilizer, but the ... in manure is ever present. The ratio of nitrogen to ... needs of most crops. Therefore, crops tend to be overloaded ... but the excess phosphorus from the process can damage the ...
... "The rapid translation of biologically-based laboratory discoveries into daily ... trip back from the clinic to the laboratory, to ... behavior. It is imperative for basic researchers to understand ... the knowledge and skills to integrate and use new ...
Cached Biology News:€12 million ($16.9 million) project to develop new tools for malaria control 2
(Date:7/25/2014)... Lawrence Livermore scientists Charles Westbrook and William ... " The World's Most Influential Scientific Minds ." , ... who were identified by analyzing citation data over the ... highest-impact work (2002-2012 and 2012-2013). The two were selected ... . , "This recognition is a great honor for ...
(Date:7/24/2014)... - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) ... long-term, randomized, active control Phase 3 study of Zerenex ... binder, for the treatment of hyperphosphatemia in patients with ... (PhosphatE binding and iRon delivery with FErric CiTrate in ... of the American Society of Nephrology ( JASN ...
(Date:7/24/2014)... Calif. , July 24, 2014  ECC West ... Denver, Colorado with University College Hospital (UCH) ... a development project to finance, design, construct, and operate ... Nigeria . Under the first of ... prepare scoping documents and funding applications. UCH Ibadan intends ...
(Date:7/24/2014)... and synthetic processes prefer to settle into equilibriuma ... is within the realm of non-equilibrium conditions where ... in energy and phases, such as temperature fluctuations, ... humans to regulate their body temperature, airplanes to ... activity. , But even though these conditions ...
Breaking Biology Technology:Scientists Burst onto Influential List for Combustion Research 2Scientists Burst onto Influential List for Combustion Research 3Scientists Burst onto Influential List for Combustion Research 4Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria 2New approach to form non-equilibrium structures 2
... SAN DIEGO, Oct. 4 Orexigen® Therapeutics, Inc. (Nasdaq: ... the treatment of obesity, today announced the schedule of ... taking place at the 28th Annual Scientific Meeting of ... the San Diego Convention Center, October 8-12, 2010.Sunday, October ...
... PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) ... special dividend payment of $0.50 per share to all stockholders ... record date. As previously announced, the conversion ... 15, 2012 was adjusted to 140.571 shares of common stock ...
... 1 Biotech posted its strongest monthly and quarterly performance ... September rally for equities in more than 70 years. The ... and 13 percent in the third quarter. The Dow Jones ... appreciation during what historically has been a bad month for ...
Cached Biology Technology:Orexigen® Therapeutics Announces Upcoming Data Presentations at the 28th Annual Scientific Meeting of The Obesity Society 2Biotech Posts Strong Third Quarter Performance as Capital Markets Go on a Tear 2Biotech Posts Strong Third Quarter Performance as Capital Markets Go on a Tear 3Biotech Posts Strong Third Quarter Performance as Capital Markets Go on a Tear 4
UltraPure DNase/RNase-Free Distilled Water is designed for use in all molecular biology applications. It is 0.1-m membrane-filtered and tested for DNase and RNase activity....
...
... suitable for use with RNA. ... with 0.1% diethylpyrocarbonate (DEPC) and ... DEPC.DNase/RNase-Free Distilled WaterDistilled Water is ... molecular biology applications. It is ...
IHC detection kit for BrdU in cells and tissues...
Biology Products: